Skip to main content

Vascular disease is the commonest cause of death in Westernized countries and its incidence is on the increase in developing countries. It follows that considerable research is directed at establishing effective treatment for acute vascular events. Long-term treatment has also received considerable attention (e.g. for symptomatic relief). Furthermore, effective prevention, whether primary or secondary, is backed by the findings of several landmark trials.

Vascular disease is a complex field with primary care physicians and nurse practitioners as well as several specialties involved. The latter include cardiology, vascular and cardio thoracic surgery, general medicine, radiology, clinical pharmacology and neurology (stroke units). Current Vascular Pharmacology will publish reviews to update all those concerned with the treatment of vascular disease. For example, reviews commenting on recently published trials or new drugs will be included. In addition to clinically relevant topics we will consider 'research-based' reviews dealing with future developments and potential drug targets. Therefore, another function of Current Vascular Pharmacology is to bridge the gap between clinical practice and ongoing research.

Debates will also be encouraged in the correspondence section of this journal.

Publisher: Bentham Science Publishers

Volume 10, Number 6, November 2012

Articles

ACKNOWLEDGEMENTS
pp. i-i(1)

Favourites:
ADD

Dysglycemia and Abdominal Obesity
pp. 678-679(2)
Author: Standl, Eberhard

Favourites:
ADD

Impact of Pre-Diabetes and Diabetes on Cardiovascular Outcomes
pp. 680-683(4)
Authors: Anselmino, Matteo; Sillano, Dario

Favourites:
ADD

Mechanisms of Diabetic Dyslipidemia: Relevance for Atherogenesis
pp. 684-686(3)
Authors: Arca, Marcello; Pigna, Giovanni; Favoccia, Carla

Favourites:
ADD

Glucose and LDL Lowering: The Need for Intensive Therapy
pp. 687-689(3)
Author: Del Prato, Stefano

Favourites:
ADD

Joint ESC/EASD Guidelines on Diabetes, where are we Now and where should we Go?
pp. 690-692(3)
Authors: Ryden, Lars; Mellbin, Linda

Favourites:
ADD

SIRT1 - An Anti-Inflammatory Pathway at the Crossroads Between Metabolic Disease and Atherosclerosis
pp. 693-696(4)
Authors: Winnik, Stephan; Stein, Sokrates; M. Matter, Christian

Favourites:
ADD

p66 Shc as the Engine of Vascular Aging
pp. 697-699(3)
Authors: Paneni, Francesco; Cosentino, Francesco

Favourites:
ADD
Favourites:
ADD

Decreasing Arterial Aging by Controlling Blood Pressure Levels and Hypertension: A Step Forward
pp. 702-704(3)
Authors: Scuteri, Angelo; Guimaraes Cunha, Pedro

Favourites:
ADD
Favourites:
ADD

Global Cardiovascular Risk Management in Primary Prevention
pp. 709-711(3)
Authors: Volpe, Massimo; Tocci, Giuliano

Favourites:
ADD
Favourites:
ADD

Getting Patients to Target- Implementing the Guidelines
pp. 715-717(3)
Author: Giannuzzi, Pantaleo

Favourites:
ADD

High Density Lipoprotein - Should we Raise it?
pp. 718-719(2)
Author: Landmesser, Ulf

Favourites:
ADD

Therapeutic Targets to Raise HDL in Patients at Risk or with Coronary Artery Disease
pp. 720-724(5)
Authors: F. Luscher, Thomas; von Eckardstein, Arnold; Simic, Branko

Favourites:
ADD

Lessons from the REACH Registry in Europe
pp. 725-727(3)
Authors: M. Valentijn, Tabita; J. Stolker, Robert

Favourites:
ADD

How to Identify Subjects with Poly-Vascular Disease?
pp. 728-730(3)
Authors: Vlachopoulos, Charalambos; Terentes-Printzios, Dimitrios; Stefanadis, Christodoulos

Favourites:
ADD
Favourites:
ADD

Treatment of Carotid Stenosis
pp. 734-738(5)
Author: Touze, Emmanuel

Favourites:
ADD

Hypertension: Quo Vadis?
pp. 739-742(4)
Author: Borghi, Claudio

Favourites:
ADD

Lipids and Non-Cardiac Vascular Disease: A Lecture Overview
pp. 743-744(2)
Author: P. Mikhailidis, Dimitri

Favourites:
ADD

Editorial: (Aliskiren/Amlodipine Single-Pill Combinations: More Evidence in Favour of Combination Formulations for the Treatment of Hypertension)
pp. 745-747(3)
Authors: Katsiki, Niki; G. Athyros, Vasilios; P. Mikhailidis, Dimitri; Karagiannis, Asterios

Favourites:
ADD

Antihypertensive Efficacy and Tolerability of Aliskiren/Amlodipine Single- Pill Combinations in Patients with an Inadequate Response to Aliskiren Monotherapy¥
pp. 748-755(8)
Authors: Glorioso, Nicola; Thomas, Mathew; Troffa, Chiara; Argiolas, Giuseppe; Patel, Samir; Baek, Inyoung; Zhang, Jack

Favourites:
ADD

Molecular Link between Intravascular Hemolysis and Vascular Occlusion in Sickle Cell Disease
pp. 756-761(6)
Authors: Zhou, Zhou; L. Yee, Donald; Guchhait, Prasenjit

Favourites:
ADD
Favourites:
ADD

Statins and Portal Hypertension: A New Pharmacological Challenge
pp. 767-772(6)
Authors: Ramirez, Gonzalo; Briceno, Jimmy; Rojas, Armando

Favourites:
ADD
Favourites:
ADD

The Effects of Incretins on Energy Homeostasis: Physiology and Implications for the Treatment of Type 2 Diabetes Mellitus and Obesity
pp. 781-791(11)
Authors: Karras, Spyridon; G. Goulis, Dimitrios; Mintziori, Gesthimani; Katsiki, Niki; Tzotzas, Themistoklis

Favourites:
ADD

Access Key

Free Content
Free content
New Content
New content
Open Access Content
Open access content
Subscribed Content
Subscribed content
Free Trial Content
Free trial content
Cookie Policy
X
Cookie Policy
ingentaconnect website makes use of cookies so as to keep track of data that you have filled in. I am Happy with this Find out more